38th Annual Society for Immunotherapy of Cancer (SITC) Meeting

Advertisement
Advertisement
Novel CLN-978 Elicited ‘Potent Efficacy’ Against B-cell Lymphoma Cells
Melissa BadamoAggressive B-Cell Lymphoma | November 9, 2023
CLN-978 was designed for high-affinity binding to CD19 and to enable the killing of low-CD19 expressing blasts.
Read More
Novel Analysis Strategy Detects MRD in T-ALL
Melissa BadamoAcute Lymphoblastic Leukemia | November 6, 2023
The strategy is “potentially translatable to all T-cell derived hematological malignancies," according to researchers.
Read More
Emavusertib Could Lead to 'Improved Disease Outcomes' for Patients with AML or MDS
Melissa BadamoAcute Myeloid Leukemia | November 6, 2023
RNA sequencing showed decreased gene expression levels of the NF-κB target genes IL1β and IER3 after emavusertib treatment.
Read More
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy